Citation APA
van Aken, E. E., Gandhi, A. K., O'Cathail, S. S., Borst, G. R., Barriuso, J., Fokas, E., Castelo-Branco, L., Ree, A. H., de Azambuja, E., Kroeze, S., Colombo, I., Levy, A., Criscitiello, C., Niyazi, M., Harbeck, N., Szutowicz, E., Liposits, G., Verheij, M., Ray-Coquard, I., Tarantino, P., Trapani, D., Boot, P., Belka, C., Ruysscher, D. D., Pentheroudakis, G., Marijnen, C. C., Lordick, F., Ricardi, U., Martins-Branco, D., Prelaj, A., de Jong, M. M., & Devnani, B. (2026). ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors. Radiotherapy and oncology, 215, 111330. doi:10.1016/j.radonc.2025.111330
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/406142